A Lyme Disease Vaccine Is Coming, But Experts Warn of a Major Catch in Pfizer’s Research

A Lyme Disease Vaccine Is Coming, But Experts Warn of a Major Catch in Pfizer’s Research

Pfizer's shot fell short of its trial goal, but with nearly half a million Americans infected each year, the company isn't giving up.

Amid rising cases of Lyme disease in Ontario, new Pfizer vaccine one step closer to reality

Pfizer and Valneva are seeking U.S. approval for a new human Lyme disease vaccine that proved more than 70 per cent effective in trials, including in Canada.

Pfizer seeks FDA approval for new Lyme disease vaccine candidate

When Lyme disease makes the news, it's typically not for positive reasons — but Pfizer is gearing up to seek regulatory approval for a new vaccine candidate, CNBC reported. In April 2020, Pfizer and French vaccine company Valneva announced plans to jointly "develop and commercialize Valneva's Lyme disease vaccine candidate VLA15," which was in Phase 2 of development at the time (explained here by the Centers for Disease Control and Prevention). …